Most B2B marketing treats the buyer as a single person. In medical devices, the buyer is often a committee.
A surgeon has to trust the device. A procurement lead has to trust the vendor. A hospital committee has to trust the governance and the budget case. Three different people, three different sets of psychology, one purchase decision that might take years to land. Market to this like it’s one person and you’ll get nowhere.
LinkedIn is a channel built to handle this properly. You can identify people by role and by organisation, which means you can actually have multiple different conversations instead of one generic one.
Build the personas properly
The temptation is to write a single “healthcare professional” persona and call it done. Don’t. Go through each of the three audiences and interrogate them on five points:
- What do they want?
- What don’t don’t want?
- What are their pain points?
- Why they aren’t already contacting you
- What is their catalyst for change?
Done properly, this gives you a page of insights for each person, and it means that when you sit down to write content, you can genuinely change hats rather than writing the same message three times, with different job titles swapped in.
The differences are stark once you map them out. Surgeons and clinicians want peer validation, clinical evidence and proof of outcomes. Procurement and supply chain leads care about cost, compliance and whether the vendor is reliable over the long haul. Hospital committees are thinking governance, risk and where this sits in the budget cycle. A generic LinkedIn post trying to speak to all three at once ends up speaking to none of them.
There’s a regulatory layer sitting under all of this too. Advertising to surgeons and other registered health professionals gives you more room to be direct about clinical detail than advertising that’s visible to the general public, which is bound by the Therapeutic Goods Advertising Code. Content aimed at health care professionals only can go deeper, provided it’s genuinely gated so the public can’t see it. Content that’s publicly visible has to stay balanced and substantiated, and if you’re citing clinical research, people need to be able to find the details of that research and know who funded it. It’s worth getting proper advice on where your specific content sits before you publish, but the short version is: know your audience gate before you decide how far you can go.
None of this happens fast. Hospital procurement can take months, sometimes years, and clinicians are notoriously allergic to being sold to. They want evidence and credibility established well before anyone asks for a decision that affects a patient on their table.
Earn trust before you ask for anything.
So the content has to do the work of earning trust with each audience separately. Evidence and outcomes for surgeons. ROI and compliance detail for procurement. Governance-friendly material for the committee.
Organic content is where this trust gets built over time, and it tends to fall into four buckets:
- Showing the humans behind the company so people warm to you
- Teaching people something genuinely useful about the device
- Providing evidence
- The occasional call to action, delivered politely and sparingly, because healthcare professionals switch off fast when they smell a pitch.
Paid sits alongside this rather than replacing it. You can build tightly targeted audiences by job role and organisation and put your message in front of them consistently, either as standalone paid content or by boosting the organic posts that are already landing. Watch how your specific audience size responds, though. What performs for a broad audience won’t necessarily perform for a narrow one, and content that stays “always on” without rotation goes stale fast with a small, repeatedly exposed group. Refreshing weekly, fortnightly or monthly is often the difference between being relevant and becoming wallpaper.
Make it measurable and give it time
Practically, this means a content calendar that tracks who’s posting what organically and what’s running paid alongside it, and measurement at three levels:
- Awareness (did the right people see it)
- Engagement (did they act on it, even just visiting the site)
- Leads (did they actually get in touch).
How long before any of this shows up in the pipeline depends on where you’re starting from. An established brand with existing awareness moves faster than a new product getting established. And the more people sitting around that buying committee table, the slower the whole thing tends to move, no matter how good the content is.
That’s the trade you’re making with a channel like this. It’s slower and more deliberate than most B2B marketing, because you’re not selling to a person; you’re building trust with a committee, one persona at a time.
